{"id":"https://openalex.org/W3002396473","doi":"https://doi.org/10.1016/j.bbmt.2019.12.714","title":"Preclinical Development of an Actinium-225-Labeled Antibody Radio-Conjugate Directed Against CD45 for Targeted Conditioning and Radioimmunotherapy","display_name":"Preclinical Development of an Actinium-225-Labeled Antibody Radio-Conjugate Directed Against CD45 for Targeted Conditioning and Radioimmunotherapy","publication_year":2020,"publication_date":"2020-01-23","ids":{"openalex":"https://openalex.org/W3002396473","doi":"https://doi.org/10.1016/j.bbmt.2019.12.714","mag":"3002396473"},"language":"en","primary_location":{"id":"doi:10.1016/j.bbmt.2019.12.714","doi":"https://doi.org/10.1016/j.bbmt.2019.12.714","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.bbmt.2019.12.714","pdf_url":null,"source":{"id":"https://openalex.org/S59987174","display_name":"Transplantation and Cellular Therapy","issn_l":"1083-8791","issn":["1083-8791","1523-6536","2666-6367"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biology of Blood and Marrow Transplantation","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.bbmt.2019.12.714","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111662248","display_name":"Dale L. Ludwig","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dale L. Ludwig","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089681126","display_name":"Ruth A. Bryan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ruth A. Bryan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038643576","display_name":"Wojciech Dawicki","orcid":"https://orcid.org/0009-0008-7628-961X","observed_orcids":["https://orcid.org/0009-0008-7628-961X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wojciech Dawicki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062757242","display_name":"Eileen M. Geoghegan","orcid":"https://orcid.org/0000-0003-3068-3503","observed_orcids":["https://orcid.org/0000-0003-3068-3503"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eileen M. Geoghegan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045543125","display_name":"Qing Liang","orcid":"https://orcid.org/0000-0002-3281-2607","observed_orcids":["https://orcid.org/0000-0002-3281-2607"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qing Liang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040272524","display_name":"Mamata S Gokhale","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mamata Gokhale","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026834279","display_name":"Vijay S. Reddy","orcid":"https://orcid.org/0000-0003-4638-8277","observed_orcids":["https://orcid.org/0000-0003-4638-8277"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vijay Reddy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065251951","display_name":"Ravendra Garg","orcid":"https://orcid.org/0000-0001-5161-8300","observed_orcids":["https://orcid.org/0000-0001-5161-8300"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ravendra Garg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037136421","display_name":"Kevin J H Allen","orcid":"https://orcid.org/0000-0002-6019-472X","observed_orcids":["https://orcid.org/0000-0002-6019-472X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kevin J.H. Allen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113624290","display_name":"Mark S. Berger","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark S. Berger","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5034610205","display_name":"Ekaterina Dadachova","orcid":"https://orcid.org/0000-0001-7300-6479","observed_orcids":["https://orcid.org/0000-0001-7300-6479"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ekaterina Dadachova","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3650,"currency":"USD","value_usd":3650},"apc_paid":{"value":3650,"currency":"USD","value_usd":3650},"fwci":0.3669,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.56763623,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"26","issue":"3","first_page":"S160","last_page":"S161"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13561","display_name":"Chemical Reactions and Isotopes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/actinium-225","display_name":"actinium-225","score":0.9739999771118164},{"id":"https://openalex.org/keywords/anti-cd45-antibody","display_name":"anti-CD45 antibody","score":0.8199999928474426},{"id":"https://openalex.org/keywords/bone-marrow-transplantation","display_name":"bone marrow transplantation","score":0.6980000138282776},{"id":"https://openalex.org/keywords/radioimmunotherapy","display_name":"radioimmunotherapy","score":0.8820000290870667},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9259999990463257},{"id":"https://openalex.org/keywords/alpha-emitting-radionuclide","display_name":"alpha-emitting radionuclide","score":0.6990000009536743},{"id":"https://openalex.org/keywords/dota-chelator","display_name":"DOTA chelator","score":0.8790000081062317},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.6520000100135803},{"id":"https://openalex.org/keywords/tumor-xenografts","display_name":"tumor xenografts","score":0.6539999842643738},{"id":"https://openalex.org/keywords/spect-ct-imaging","display_name":"SPECT/CT imaging","score":0.7329999804496765}],"concepts":[{"id":"https://openalex.org/C2776146153","wikidata":"https://www.wikidata.org/wiki/Q7281276","display_name":"Radioimmunotherapy","level":4,"score":0.9633812308311462},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9028589725494385},{"id":"https://openalex.org/C197336794","wikidata":"https://www.wikidata.org/wiki/Q5161150","display_name":"Conjugate","level":2,"score":0.7052050828933716},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.40227609872817993},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.26654964685440063},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.21321603655815125},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.16528722643852234},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0},{"id":"https://openalex.org/C134306372","wikidata":"https://www.wikidata.org/wiki/Q7754","display_name":"Mathematical analysis","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.bbmt.2019.12.714","doi":"https://doi.org/10.1016/j.bbmt.2019.12.714","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.bbmt.2019.12.714","pdf_url":null,"source":{"id":"https://openalex.org/S59987174","display_name":"Transplantation and Cellular Therapy","issn_l":"1083-8791","issn":["1083-8791","1523-6536","2666-6367"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biology of Blood and Marrow Transplantation","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.bbmt.2019.12.714","doi":"https://doi.org/10.1016/j.bbmt.2019.12.714","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.bbmt.2019.12.714","pdf_url":null,"source":{"id":"https://openalex.org/S59987174","display_name":"Transplantation and Cellular Therapy","issn_l":"1083-8791","issn":["1083-8791","1523-6536","2666-6367"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biology of Blood and Marrow Transplantation","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.800000011920929}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2030765561","https://openalex.org/W7095724811","https://openalex.org/W4405040078","https://openalex.org/W2513391787","https://openalex.org/W2173191675","https://openalex.org/W2980299075","https://openalex.org/W1904298553","https://openalex.org/W2594600397","https://openalex.org/W124412411","https://openalex.org/W2032451420"],"abstract_inverted_index":{"Introduction":[0],"Radiolabeled":[2],"CD45":[3,37,179,293],"antibodies":[4,322],"have":[5],"demonstrated":[6],"clinical":[7],"promise":[8],"as":[9,19,406],"targeted":[10,64,324,412],"conditioning":[11,35,325,340,413],"agents":[12],"prior":[13,326],"to":[14,28,145,152,313,327,354,366,391],"bone":[15],"marrow":[16],"transplant":[17],"(BMT)":[18],"a":[20,81,91,134,235,309,407],"better":[21],"tolerated":[22],"and":[23,48,51,54,113,128,148,157,183,200,227,262,317,358,369,376,396,410],"potentially":[24],"more":[25],"effective":[26],"alternative":[27],"chemotherapy":[29],"and/or":[30],"total":[31],"body":[32],"irradiation":[33],"myeloablative":[34,318],"regimens.":[36],"is":[38,69,308],"expressed":[39,72],"on":[40,73],"all":[41],"immune":[42,387],"cells,":[43,56],"including":[44,389],"hematopoietic":[45],"stem":[46],"cells":[47,154,333,375],"both":[49,208,257],"precursor":[50],"mature":[52],"lymphoid":[53],"myeloid":[55],"making":[57],"it":[58],"an":[59,246,289],"ideal":[60],"antigen":[61,180],"for":[62,66,80,266,323,415],"directing":[63],"radiation":[65],"conditioning.":[67],"It":[68],"also":[70],"highly":[71],"most":[74],"hematological":[75],"cancers,":[76],"offering":[77],"the":[78,87,99,105,125,161,212,267,273,315,361,386,402],"potential":[79,214],"substantial":[82],"anti-tumor":[83,162,218,278],"effect.":[84,279],"We":[85],"describe":[86],"preclinical":[88,394],"development":[89,403],"of":[90,98,164,207,215,225,238,241,245,269,272,320,338,372,385,404],"novel":[92,408],"anti-CD45":[93],"antibody":[94,101,118,295,350],"radio-conjugate":[95,248],"that":[96],"consists":[97],"pan-CD45":[100,349],"BC8":[102,119,251,299,351],"labeled":[103,130,359],"with":[104,124,131,174,285,304,360],"potent":[106,362,409],"alpha":[107,363],"emitter":[108,364],"Actinium-225":[109],"(225Ac).":[110],"Methods":[112],"Results":[114,337],"The":[116,348],"monoclonal":[117],"(apamistamab)":[120],"was":[121,143,220,352],"first":[122],"conjugated":[123,357],"DOTA":[126],"chelator":[127],"then":[129],"225Ac,":[132],"achieving":[133],"labeling":[135],"efficiency":[136],"typically":[137],"greater":[138,202],"than":[139,203],"80%.":[140],"Furthermore,":[141],"225Ac-BC8":[142,259,405],"shown":[144,353],"be":[146,343,355],"stable":[147],"retain":[149],"selective":[150,370,381],"immunoreactivity":[151],"CD45+":[153,167,373],"following":[155],"conjugation":[156],"labeling.":[158],"To":[159,210],"evaluate":[160],"potency":[163],"225Ac-BC8,":[165,216,242],"two":[166],"human":[168],"multiple":[169],"myeloma":[170],"(MM)":[171],"cell":[172,197,205],"lines":[173],"high":[175],"or":[176,253],"low":[177],"relative":[178],"density,":[181],"U266":[182],"H929,":[184],"respectively,":[185],"(Collette,":[186],"et":[187],"al.":[188],"2007":[189],"Eur.":[190],"Cytokine":[191],"Netw.":[192],"18:120-126)":[193],"were":[194,283],"tested":[195,221],"by":[196],"cytotoxicity":[198],"assay":[199],"achieved":[201],"90%":[204],"killing":[206,371],"lines.":[209],"assess":[211],"therapeutic":[213],"its":[217],"activity":[219],"in":[222,334],"xenograft":[223],"models":[224],"H929":[226],"U266.":[228],"NOD-SCID":[229],"mice":[230],"bearing":[231],"established":[232],"tumors":[233],"received":[234],"single":[236],"dose":[237],"300":[239,243],"nCi":[240,244],"irrelevant":[247],"225Ac-18B7,":[249],"naked":[250],"antibody,":[252],"no":[254],"treatment.":[255],"In":[256],"models,":[258],"exerted":[260],"complete":[261],"durable":[263],"tumor":[264],"control":[265,274],"duration":[268],"study.":[270],"None":[271],"groups":[275],"exhibited":[276],"any":[277],"Favorable":[280],"biodistribution":[281],"results":[282],"obtained":[284],"SPECT/CT":[286],"imaging":[287],"using":[288,330],"111In-labeled":[290],"mouse":[291,305],"pan":[292],"surrogate":[294,311],"30F11":[296],"(111Ac-30F11),":[297],"since":[298],"does":[300],"not":[301],"cross":[302],"react":[303],"CD45.":[306],"225Ac-30F11":[307],"useful":[310],"molecule":[312],"study":[314],"tolerability":[316],"properties":[319],"225Ac-anti-CD45":[321],"donor":[328,332],"BMT,":[329],"B6-Ly5b":[331],"B6-Ly5a":[335],"mice.":[336],"ongoing":[339,397],"studies":[341,400],"will":[342],"presented.":[344],"Conclusions":[346],"efficiently":[356],"225Ac":[365],"mediate":[367],"robust":[368],"MM":[374],"xenografts.":[377],"Biodistribution":[378],"analysis":[379],"confirmed":[380],"uptake":[382],"into":[383],"organs":[384],"system":[388],"homing":[390],"BM.":[392],"These":[393],"data":[395],"myeloablative/BM":[398],"reconstitution":[399],"support":[401],"safe":[411],"approach":[414],"BMT.":[416]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2020-01-30T00:00:00"}